Anatol Kontush

15.7k total citations · 3 hit papers
163 papers, 11.7k citations indexed

About

Anatol Kontush is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Anatol Kontush has authored 163 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Endocrinology, Diabetes and Metabolism, 60 papers in Surgery and 49 papers in Molecular Biology. Recurrent topics in Anatol Kontush's work include Diabetes, Cardiovascular Risks, and Lipoproteins (72 papers), Antioxidant Activity and Oxidative Stress (42 papers) and Lipoproteins and Cardiovascular Health (41 papers). Anatol Kontush is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (72 papers), Antioxidant Activity and Oxidative Stress (42 papers) and Lipoproteins and Cardiovascular Health (41 papers). Anatol Kontush collaborates with scholars based in France, Germany and United States. Anatol Kontush's co-authors include M. John Chapman, M. John Chapman, Sandrine Chantepie, Ulrike Beisiegel, M. John Chapman, Marie Lhomme, Barbara Finckh, Laurent Camont, W. Sean Davidson and Alfried Kohlschütter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Anatol Kontush

161 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis

2006 598 citations Anatol Kontush, M. John Chapman profile →
Dysfunctional HDL and atherosclerotic cardiovascular disease

2015 567 citations M. John Chapman, Anatol Kontush et al. profile →
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events

2011 391 citations M. John Chapman, Anatol Kontush et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anatol Kontush France	55	4.6k	4.2k	3.0k	1.8k	1.6k	163	11.7k
Srinivasa T. Reddy United States	67	3.3k 0.7×	4.4k 1.1×	4.5k 1.5×	1.5k 0.9×	2.5k 1.5×	245	15.7k
Susan Hama United States	53	3.6k 0.8×	4.5k 1.1×	2.8k 0.9×	1.4k 0.8×	1.2k 0.8×	75	12.9k
M. John Chapman France	62	5.6k 1.2×	7.7k 1.8×	2.7k 0.9×	2.9k 1.6×	2.5k 1.5×	197	15.0k
Paul Holvoet Belgium	62	1.7k 0.4×	2.7k 0.6×	3.5k 1.1×	2.2k 1.2×	1.9k 1.2×	174	12.0k
Cesare R. Sirtori Italy	66	4.9k 1.1×	6.5k 1.6×	3.9k 1.3×	2.6k 1.5×	1.9k 1.2×	393	15.2k
Kerry‐Anne Rye Australia	65	5.1k 1.1×	6.2k 1.5×	4.7k 1.5×	2.0k 1.1×	2.4k 1.5×	266	13.4k
M. John Chapman France	50	5.6k 1.2×	8.2k 2.0×	2.2k 0.7×	3.3k 1.8×	2.4k 1.5×	134	14.1k
Tony Hayek Israel	47	2.3k 0.5×	2.8k 0.7×	2.4k 0.8×	1.5k 0.8×	787 0.5×	111	9.8k
Jeffrey S. Cohn Canada	53	3.9k 0.9×	3.0k 0.7×	2.3k 0.8×	1.9k 1.1×	1.1k 0.7×	113	9.6k
N.E. Miller United Kingdom	53	6.1k 1.3×	5.5k 1.3×	2.1k 0.7×	2.2k 1.2×	1.9k 1.2×	161	11.9k

Countries citing papers authored by Anatol Kontush

Since Specialization

Citations

This map shows the geographic impact of Anatol Kontush's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anatol Kontush with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anatol Kontush more than expected).

Fields of papers citing papers by Anatol Kontush

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anatol Kontush. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anatol Kontush. The network helps show where Anatol Kontush may publish in the future.

Co-authorship network of co-authors of Anatol Kontush

This figure shows the co-authorship network connecting the top 25 collaborators of Anatol Kontush. A scholar is included among the top collaborators of Anatol Kontush based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anatol Kontush. Anatol Kontush is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abashkin, Viktar, Dzmitry Shcharbin, Wilfried Le Goff, et al.. (2025). High-density lipoprotein-like nanoparticles with cationic cholesterol derivatives for siRNA delivery. Biomaterials Advances. 170. 214202–214202.

Ganjali, Shiva, et al.. (2023). Capacity of HDL to Efflux Cellular Cholesterol from Lipid-Loaded Macrophages Is Reduced in Patients with Familial Hypercholesterolemia. Metabolites. 13(2). 197–197. 7 indexed citations

Gomaraschi, Monica, Marie Lhomme, Chiara Pavanello, et al.. (2023). Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency. Antioxidants. 12(8). 1498–1498. 2 indexed citations

Pavanello, Chiara, Alice Ossoli, Wilfried Le Goff, et al.. (2023). Both low and extremely high monogenic HDL-cholesterol states are characterised by defective capacity of HDL to acquire free cholesterol upon triglyceride lipolysis. Atherosclerosis. 379. S59–S59.

Bekshaev, A. Ya., et al.. (2022). Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL. Metabolites. 12(7). 623–623. 4 indexed citations

Stadler, Julia T., Andelko Hrzenjak, Andrea Berghold, et al.. (2021). Endothelial Lipase Modulates Paraoxonase 1 Content and Arylesterase Activity of HDL. International Journal of Molecular Sciences. 22(2). 719–719. 9 indexed citations

Kontush, Anatol. (2020). HDL and Reverse Remnant-Cholesterol Transport (RRT): Relevance to Cardiovascular Disease. Trends in Molecular Medicine. 26(12). 1086–1100. 63 indexed citations

Rached, Fabiana Hanna, Marie Lhomme, Maharajah Ponnaiah, et al.. (2019). Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiency. Journal of clinical lipidology. 13(3). 468–480.e8. 15 indexed citations

Rached, Fabiana Hanna, et al.. (2018). Impact of Lipoproteins on Atherobiology. Cardiology Clinics. 36(2). 193–201. 10 indexed citations

10.

Rosso, Leonardo Gómez, Marie Lhomme, Tomás Meroño, et al.. (2017). Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c Molecular and cell biology of lipids. Biochimica et Biophysica Acta. 2 indexed citations

11.

Hancock‐Cerutti, William, et al.. (2017). Paradoxical coronary artery disease in humans with hyperalphalipoproteinemia is associated with distinct differences in the high-density lipoprotein phosphosphingolipidome. Journal of clinical lipidology. 11(5). 1192–1200.e3. 8 indexed citations

12.

Thérond, Patrice, Svetlana A. Didichenko, Isabelle Guillas, et al.. (2017). Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1862(9). 890–900. 9 indexed citations

13.

Hansel, Boris, Dominique Bonnefont‐Rousselot, Alexina Orsoni, et al.. (2016). Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels. Journal of clinical lipidology. 10(5). 1172–1181. 11 indexed citations

14.

Kim, Mi‐Jurng, Liming Hou, Wilfried Le Goff, et al.. (2015). HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export. Circulation Research. 116(7). 1133–1142. 240 indexed citations

15.

Rached, Fabiana Hanna, Marie Lhomme, Laurent Camont, et al.. (2015). Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851(9). 1254–1261. 46 indexed citations

16.

Rosso, Leonardo Gómez, Marie Lhomme, Tomás Meroño, et al.. (2014). Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: Relevance of inflammation. Atherosclerosis. 237(2). 652–660. 53 indexed citations

17.

Ménézo, Y., et al.. (2013). Distinct profiles of systemic biomarkers of oxidative stress in chronic human pathologies: Cardiovascular, psychiatric, neurodegenerative, rheumatic, infectious, neoplasmic and endocrinological diseases. Advances in Bioscience and Biotechnology. 4(3). 331–339. 7 indexed citations

18.

Chantepie, Sandrine, Andrea E. Bochem, M. John Chapman, G. Kees Hovingh, & Anatol Kontush. (2012). High-Density Lipoprotein (HDL) Particle Subpopulations in Heterozygous Cholesteryl Ester Transfer Protein (CETP) Deficiency: Maintenance of Antioxidative Activity. PLoS ONE. 7(11). e49336–e49336. 28 indexed citations

19.

Kontush, Anatol, et al.. (2001). Resistance of human cerebrospinal fluid toin vitrooxidation is directly related to its amyloid-β content. Free Radical Research. 35(5). 507–517. 31 indexed citations

20.

Djahansouzi, S., et al.. (2001). The effect of pharmacological doses of different antioxidants on oxidation parameters and atherogenesis in hyperlipidaemic rabbits. Atherosclerosis. 154(2). 387–398. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact